Brooks Laboratories Ltd
NSE:BROOKS

Watchlist Manager
Brooks Laboratories Ltd Logo
Brooks Laboratories Ltd
NSE:BROOKS
Watchlist
Price: 159.99 INR 2% Market Closed
Market Cap: 4.2B INR
Have any thoughts about
Brooks Laboratories Ltd?
Write Note

Gross Margin
Brooks Laboratories Ltd

29.1%
Current
26%
Average
44%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
29.1%
=
Gross Profit
237.7m
/
Revenue
817.2m

Gross Margin Across Competitors

Country IN
Market Cap 4.2B INR
Gross Margin
29%
Country US
Market Cap 1.2T USD
Gross Margin
55%
Country US
Market Cap 200.4B USD
Gross Margin
41%
Country US
Market Cap 165.1B USD
Gross Margin
60%
Country KR
Market Cap 66.8T KRW
Gross Margin
49%
Country CH
Market Cap 38.3B CHF
Gross Margin
29%
Country US
Market Cap 38.7B USD
Gross Margin
55%
Country US
Market Cap 35.8B USD
Gross Margin
35%
Country US
Market Cap 26.7B USD
Gross Margin
59%
Country US
Market Cap 24B USD
Gross Margin
35%
Country CN
Market Cap 162.5B CNY
Gross Margin
40%
No Stocks Found

Brooks Laboratories Ltd
Glance View

Market Cap
4.2B INR
Industry
Life Sciences Tools & Services

Brooks Laboratories Ltd. is a research and development driven pharmaceutical manufacturing company. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2011-09-02. The firm operates through the Pharmaceuticals segment. The company manufactures various pharmaceutical dosage forms, including injections, tablets, dry syrup and eye/ear drops. Its products under Carbapenem category includes Imipenem 250mg + Cilastatin 250mg, Imipenem 500mg + Cilastatin 500mg, Meropenem 125mg, Meropenem 250mg, Meropenem 500mg, Meropenem 1000mg, Meropenem 1000mg+Sulbactam 500mg, Meropenem 1000mg+Tazobactam 500mg, Doripenem 500mg and Doripenem 1000mg. The company offers Penicillins in the form of injections, tablets and dry syrup. Its General category of products include liquid injections, dry powder injections and eye/ear drops. The firm has two manufacturing plants, which are located at Baddi in Himachal Pradesh and Vadodara in Gujarat. The firm manufactures and markets the pharmaceuticals nationally and internationally to various regulated markets.

BROOKS Intrinsic Value
45.18 INR
Overvaluation 72%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
29.1%
=
Gross Profit
237.7m
/
Revenue
817.2m
What is the Gross Margin of Brooks Laboratories Ltd?

Based on Brooks Laboratories Ltd's most recent financial statements, the company has Gross Margin of 29.1%.